Dual-luciferase reporter assays demonstrated that GATA3 boosted the activity of the ENTPD3-promoter reporter and that deleting the GATA3-binding site diminished GATA3-mediated activity in MDA-MB-231 breast cancer cells (Fig. 1g). Here, ENTPD3 is linked to breast cancer.